nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Active salvage chemotherapy versus best supportive care for patients with recurrent or metastatic squamous cell carcinoma of the esophagus refractory or intolerable to fluorouracil, platinum, and taxane
|
Nomura, Motoo |
|
2016 |
78 |
6 |
p. 1209-1216 |
artikel |
2 |
A phase I pharmacokinetic and safety study of cabazitaxel in adult cancer patients with normal and impaired renal function
|
Azaro, Analía |
|
2016 |
78 |
6 |
p. 1185-1197 |
artikel |
3 |
Application of bee venom and its main constituent melittin for cancer treatment
|
Liu, Cui-cui |
|
2016 |
78 |
6 |
p. 1113-1130 |
artikel |
4 |
Aromatase inhibitor-induced carpal tunnel syndrome: prevalence in daily practice
|
Soumaya, Labidi |
|
2016 |
78 |
6 |
p. 1311-1315 |
artikel |
5 |
Curcumin analog EF24 induces apoptosis via ROS-dependent mitochondrial dysfunction in human colorectal cancer cells
|
He, Guodong |
|
2016 |
78 |
6 |
p. 1151-1161 |
artikel |
6 |
Dose-dense paclitaxel plus carboplatin as neoadjuvant chemotherapy for advanced ovarian, fallopian tube, or primary peritoneal carcinomas
|
Ebata, T. |
|
2016 |
78 |
6 |
p. 1283-1288 |
artikel |
7 |
Effects of elotuzumab on QT interval and cardiac safety in patients with multiple myeloma
|
Passey, Chaitali |
|
2016 |
78 |
6 |
p. 1237-1244 |
artikel |
8 |
EGFR mutation status of paired cerebrospinal fluid and plasma samples in EGFR mutant non-small cell lung cancer with leptomeningeal metastases
|
Zhao, Jing |
|
2016 |
78 |
6 |
p. 1305-1310 |
artikel |
9 |
Enhanced anti-tumour activity of the combination of the novel MEK inhibitor WX-554 and the novel PI3K inhibitor WX-037
|
Haagensen, Emma J. |
|
2016 |
78 |
6 |
p. 1269-1281 |
artikel |
10 |
Eriocitrin from lemon suppresses the proliferation of human hepatocellular carcinoma cells through inducing apoptosis and arresting cell cycle
|
Wang, Ziyou |
|
2016 |
78 |
6 |
p. 1143-1150 |
artikel |
11 |
18F-FLT PET/CT imaging in patients with advanced solid malignancies treated with axitinib on an intermittent dosing regimen
|
Scarpelli, Matthew |
|
2016 |
78 |
6 |
p. 1245-1252 |
artikel |
12 |
Gota et al. on their article “the pharmacokinetics of Reditux™, a biosimilar of rituximab”
|
Tout, Mira |
|
2016 |
78 |
6 |
p. 1317-1318 |
artikel |
13 |
GSTP1, GSTM1, and GSTT1 polymorphisms as predictors of response to chemotherapy in patients with breast cancer: a meta-analysis
|
Kong, Xiangzhen |
|
2016 |
78 |
6 |
p. 1163-1173 |
artikel |
14 |
Lack of effect of smoking status on axitinib pharmacokinetics in patients with non-small-cell lung cancer
|
Garrett, May |
|
2016 |
78 |
6 |
p. 1131-1141 |
artikel |
15 |
Linc-ROR confers gemcitabine resistance to pancreatic cancer cells via inducing autophagy and modulating the miR-124/PTBP1/PKM2 axis
|
Li, Chenggang |
|
2016 |
78 |
6 |
p. 1199-1207 |
artikel |
16 |
Pharmacodynamic study of the oral hedgehog pathway inhibitor, vismodegib, in patients with metastatic castration-resistant prostate cancer
|
Maughan, Benjamin L. |
|
2016 |
78 |
6 |
p. 1297-1304 |
artikel |
17 |
Pharmacokinetic and pharmacodynamic study of doxorubicin in children with cancer: results of a “European Pediatric Oncology Off-patents Medicines Consortium” trial
|
Krischke, Miriam |
|
2016 |
78 |
6 |
p. 1175-1184 |
artikel |
18 |
Pharmacokinetic dose adjustment of 5-FU in modified FOLFOX7 plus bevacizumab for metastatic colorectal cancer in Japanese patients: a-JUST phase II clinical trial
|
Denda, Tadamichi |
|
2016 |
78 |
6 |
p. 1253-1261 |
artikel |
19 |
Pharmacokinetics, immunogenicity, and safety of weekly dosing of brentuximab vedotin in pediatric patients with Hodgkin lymphoma
|
Flerlage, Jamie E. |
|
2016 |
78 |
6 |
p. 1217-1223 |
artikel |
20 |
Pilot study of FMC (5-fluorouracil, mitomycin C, and cisplatin) with radiotherapy for patients with anal cancer
|
Lee, In Hee |
|
2016 |
78 |
6 |
p. 1263-1267 |
artikel |
21 |
RETRACTED ARTICLE: Linc-ROR confers gemcitabine resistance to pancreatic cancer cells via inducing autophagy and modulating the miR-124/PTBP1/PKM2 axis
|
Li, Chenggang |
|
|
78 |
6 |
p. 1199-1207 |
artikel |
22 |
Silencing of histone deacetylase 2 suppresses malignancy for proliferation, migration, and invasion of glioblastoma cells and enhances temozolomide sensitivity
|
Zhang, Zhiqiang |
|
2016 |
78 |
6 |
p. 1289-1296 |
artikel |
23 |
Therapeutic potential of taxanes in the treatment of metastatic pancreatic cancer
|
Lemstrova, Radmila |
|
2016 |
78 |
6 |
p. 1101-1111 |
artikel |
24 |
Toxicity, pharmacokinetics and metabolism of a novel inhibitor of IL-6-induced STAT3 activation
|
Kiesel, Brian F. |
|
2016 |
78 |
6 |
p. 1225-1235 |
artikel |